AUTHOR INDEX

Browse by letter:
 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Search results for: "R"
Results 91 - 100 of 512 shown below
Rasmusson, Ann M
Ann M Rasmusson, Jitka Vasek, Deborah S Lipschitz, Dolores Vojvoda, Mary Ellen Mustone, Quihu Shi, Gretchen Gudmundsen, Charles A Morgan, Jessica Wolfe and Dennis S Charney
An Increased Capacity for Adrenal DHEA Release is Associated with Decreased Avoidance and Negative Mood Symptoms in Women with PTSD
doi:10.1038/sj.npp.1300432
Neuropsychopharmacology 29, 1546-1557

Abstract | Full text | PDF |
Ann M Rasmusson, Steven M Southwick, Richard L Hauger and Dennis S Charney
Plasma Neuropeptide Y (NPY) Increases in Humans in Response to the alpha2 Antagonist Yohimbine
doi:10.1016/S0893-133X(97)00199-1
Neuropsychopharmacology 19, 95-98

Abstract | Full text | PDF |
Ann M Rasmusson, Libin Shi and Ronald Duman
Downregulation of BDNF mRNA in the Hippocampal Dentate Gyrus after Re-exposure to Cues Previously Associated with Footshock
doi:10.1016/S0893-133X(02)00286-5
Neuropsychopharmacology 27, 133-142

Abstract | Full text | PDF |
Rassnick, Stefanie
Stephen C Heinrichs, Frédérique Menzaghi, Emilio Merlo Pich, Helen A Baldwin, Stefanie Rassnick, Karen T Britton and George F Koob
Anti-Stress Action of a Corticotropin-Releasing Factor Antagonist on Behavioral Reactivity to Stressors of Varying Type and Intensity
doi:10.1038/sj.npp.1380104
Neuropsychopharmacology 11, 179-186

Abstract | PDF |
Rassoulpour, Arash
Arash Rassoulpour, Hui-Qiu Wu, Edson X Albuquerque and Robert Schwarcz
Prolonged Nicotine Administration Results in Biphasic, Brain-Specific Changes in Kynurenate Levels in the Rat
doi:10.1038/sj.npp.1300583
Neuropsychopharmacology 30, 697-704

Abstract | Full text | PDF |
Ratner, Yael
Michael Ritsner, Anatoly Gibel, Rachel Maayan, Yael Ratner, Edward Ram, Hassan Biadsy, Ilan Modai and Abraham Weizman
Cortisol/Dehydroepiandrosterone Ratio and Responses to Antipsychotic Treatment in Schizophrenia
doi:10.1038/sj.npp.1300747
Neuropsychopharmacology 30, 1913-1922

Abstract | Full text | PDF |
Ratter, Frank
Christian Benedict, Manfred Hallschmid, Katrin Schmitz, Bernd Schultes, Frank Ratter, Horst L Fehm, Jan Born and Werner Kern
Intranasal Insulin Improves Memory in Humans: Superiority of Insulin Aspart
doi:10.1038/sj.npp.1301193
Neuropsychopharmacology 32, 239-243

Abstract | Full text | PDF |
Ratti, Emiliangelo
David Walker, Yong Yang, Emiliangelo Ratti, Mauro Corsi, David Trist and Michael Davis
Differential Effects of the CRF-R1 Antagonist GSK876008 on Fear-Potentiated, Light- and CRF-Enhanced Startle Suggest Preferential Involvement in Sustained vs Phasic Threat Responses
doi:10.1038/npp.2008.210
Neuropsychopharmacology 34, 1533-1542

Abstract | Full text | PDF |
Rauch, Scott L
Scott L Rauch, Lisa M Shin, Darin D Dougherty, Nathaniel M Alpert, Alan J Fischman and Michael A Jenike
Predictors of Fluvoxamine Response in Contamination-related Obsessive Compulsive Disorder: A PET Symptom Provocation Study
doi:10.1016/S0893-133X(02)00351-2
Neuropsychopharmacology 27, 782-791

Abstract | Full text | PDF |
Karleyton C Evans, Naomi M Simon, Darin D Dougherty, Elizabeth A Hoge, John J Worthington, Candice Chow, Rebecca E Kaufman, Andrea L Gold, Alan J Fischman, Mark H Pollack and Scott L Rauch
A PET Study of Tiagabine Treatment Implicates Ventral Medial Prefrontal Cortex in Generalized Social Anxiety Disorder
doi:10.1038/npp.2008.69
Neuropsychopharmacology 34, 390-398

Abstract | Full text | PDF |
Benjamin D Greenberg, Scott L Rauch and Suzanne N Haber
Invasive Circuitry-Based Neurotherapeutics: Stereotactic Ablation and Deep Brain Stimulation for OCD
doi:10.1038/npp.2009.128
Neuropsychopharmacology 35, 317-336

Abstract | Full text | PDF |
Suzanne N Haber and Scott L Rauch
Neurocircuitry: A Window into the Networks Underlying Neuropsychiatric Disease
doi:10.1038/npp.2009.146
Neuropsychopharmacology 35, 1-3

Abstract | Full text | PDF |
Rausch, Jeffrey L
Jeffrey L Rausch, Maria E Johnson, Katherine E Kasik and Stephen M Stahl
Temperature Regulation in Depression: Functional 5HT1A Receptor Adaptation Differentiates Antidepressant Response
doi:10.1038/sj.npp.1301088
Neuropsychopharmacology aop, -

Ravaud, Alain
Michael Maes, Lucile Capuron, Alain Ravaud, Norbert Gualde, Eugene Bosmans, Belinda Egyed, Robert Dantzer and Pierre J Neveu
Lowered Serum Dipeptidyl Peptidase IV Activity is Associated with Depressive Symptoms and Cytokine Production in Cancer Patients Receiving Interleukin-2-Based Immunotherapy
doi:10.1016/S0893-133X(00)00168-8
Neuropsychopharmacology 24, 130-140

Abstract | Full text | PDF |
Ravert, Hayden
Fuji Yokoi, Gerhard Gründer, Kathleen Biziere, Massoud Stephane, Ahmet S Dogan, Robert F Dannals, Hayden Ravert, Ajit Suri, Steven Bramer and Dean F Wong
Dopamine D2 and D3 Receptor Occupancy in Normal Humans Treated with the Antipsychotic Drug Aripiprazole (OPC 14597): A Study Using Positron Emission Tomography and [11C]Raclopride
doi:10.1016/S0893-133X(02)00304-4
Neuropsychopharmacology 27, 248-259

Abstract | Full text | PDF |
Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | previous Previous | Next next
  top go to top

Extra navigation

.
ADVERTISEMENT